Oscar Health: Volatile Stock Also Offers High Option Premiums

Leveraging Oscar Health's (OSCR) high stock volatility, a cash-secured put strategy is presented as a method for investors to potentially acquire shares at a discount or generate significant premium income. For example, selling an Oct. 17 put with a $17 strike price could yield a $110 premium, establishing a break-even price of $15.90 (10.5% below Wednesday's close) and a potential 6.92% return on capital (84% annualized) if the option expires worthless. This approach allows investors willing to own OSCR to capitalize on its volatility while offsetting potential downside with premium collection, notably without immediate earnings risk.

Analysis

The article outlines a tactical options strategy for Oscar Health (OSCR), proposing the sale of cash-secured puts to capitalize on the stock's high volatility and corresponding rich option premiums. A specific example is detailed: selling an October 17 put with a $17 strike price could generate approximately $110 in premium, establishing a break-even acquisition price of $15.90, which represents a 10.5% discount from the recent close. Should the stock remain above the strike price at expiration, the trade would yield a 6.92% return on capital, or an 84% annualized return. This strategy is presented as a method for either generating income or acquiring shares at a reduced cost basis. However, the fundamental backdrop for OSCR appears mixed; while its Relative Strength Rating from Investor's Business Daily is a solid 73 out of 99, its Composite Rating is a mediocre 50 and its Earnings Per Share Rating is a weak 27. The absence of near-term earnings risk is a positive for the proposed trade's timing, but the underlying risk remains that of stock ownership in a company with questionable fundamental strength.

Key Decisions for Investors

• Investors neutral-to-bullish on Oscar Health could consider selling cash-secured puts to capitalize on high implied volatility, either for income generation or to establish a long position at a cost basis below the current market price.
• Caution is warranted due to the company's poor fundamental metrics, specifically its low IBD Earnings Per Share Rating of 27, suggesting this is a tactical volatility trade rather than a long-term fundamental investment.
• Traders must be comfortable with the obligation to purchase 100 shares per contract at the strike price and acknowledge that while the premium provides a cushion, significant downside risk comparable to direct stock ownership exists if the share price falls sharply.